Sun Pharmaceutical Industries informs about press release

01 Oct 2024 Evaluate

Sun Pharmaceutical Industries has informed that it enclosed a copy of the Press Release about Sun Pharma entering into a global exclusive commercialization, license, and supply agreement for commercializing the specialty product FIBROMUN with Philogen S.p.A, which shall be released after this intimation.

The above information is a part of company’s filings submitted to BSE.

Sun Pharma Inds. Share Price

1797.80 20.15 (1.13%)
22-Nov-2024 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1797.80
Dr. Reddys Lab 1213.90
Cipla 1486.30
Lupin 2069.95
Zydus Lifesciences 948.70
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.